AMOEBAAMOEBAAMOEBA

AMOEBA

No trades
See on Supercharts
Market capitalization
‪43.45 M‬EUR
−0.275EUR
‪−14.30 M‬EUR
0.00EUR
‪46.41 M‬
Beta (1Y)
0.15
Employees (FY)
25
Change (1Y)
0
Revenue / Employee (1Y)
0.00EUR
Net income / Employee (1Y)
‪−571.92 K‬EUR

About AMOEBA


CEO
Dominique Jean Francois Marie Doucet
Headquarters
Lyon
Founded
2010
ISIN
FR0011051598
FIGI
BBG009H7XGP7
Amoéba SA. is a lyonnaise greentech company based on chassieu whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. The company was founded by Fabrice Plasson and Jacques Bodennec on July 21, 2010 and is headquartered in Lyon, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALMIB is 0.900 EUR — it has increased by 2.86% in the past 24 hours. Watch AMOEBA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange AMOEBA stocks are traded under the ticker ALMIB.
ALMIB stock has risen by 2.27% compared to the previous week, the month change is a 11.11% rise, over the last year AMOEBA has showed a 136.84% increase.
We've gathered analysts' opinions on AMOEBA future price: according to them, ALMIB price has a max estimate of 0.82 EUR and a min estimate of 0.82 EUR. Watch ALMIB chart and read a more detailed AMOEBA stock forecast: see what analysts think of AMOEBA and suggest that you do with its stocks.
ALMIB reached its all-time high on Jan 12, 2016 with the price of 38.450 EUR, and its all-time low was 0.365 EUR and was reached on Dec 18, 2023. View more price dynamics on ALMIB chart.
See other stocks reaching their highest and lowest prices.
ALMIB stock is 4.53% volatile and has beta coefficient of 0.15. Track AMOEBA stock price on the chart and check out the list of the most volatile stocks — is AMOEBA there?
Today AMOEBA has the market capitalization of ‪43.42 M‬, it has decreased by −8.23% over the last week.
Yes, you can track AMOEBA financials in yearly and quarterly reports right on TradingView.
ALMIB net income for the last half-year is ‪−3.12 M‬ EUR, while the previous report showed ‪−10.30 M‬ EUR of net income which accounts for 69.65% change. Track more AMOEBA financial stats to get the full picture.
No, ALMIB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 25.00 employees. See our rating of the largest employees — is AMOEBA on this list?
Like other stocks, ALMIB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMOEBA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMOEBA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMOEBA stock shows the buy signal. See more of AMOEBA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.